| 前收市價 | 8.58 |
| 開市 | 8.44 |
| 買盤 | 8.09 x 200 |
| 賣出價 | 8.18 x 400 |
| 今日波幅 | 8.05 - 8.46 |
| 52 週波幅 | 6.57 - 22.93 |
| 成交量 | |
| 平均成交量 | 1,278,445 |
| 市值 | 774.177M |
| Beta 值 (5 年，每月) | 0.95 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.00 |
| 業績公佈日 | 2024年5月02日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 31.89 |
Insider Monkey13 Best Biotech Stocks To Buy Under $20
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
ZacksAkero (AKRO) Up on Upbeat Week 96 Data From Liver Disease Study
Akero (AKRO) reports positive results from its mid-stage study of efruxifermin in pre-cirrhotic metabolic dysfunction-associated steatohepatitis patients at week 96. The stock gains 12%.
ZacksWall Street Analysts Believe 89BIO (ETNB) Could Rally 121.5%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 121.5% in 89BIO (ETNB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
